Chlorella is a very relevant microalgae worldwide with a growing interest in Europe. Martinus Willem Beijerinck (1851-1931), a Dutch microbiologist was the first to identify and describe Chlorella but the industrial production started in Japan in 1964. Currently more than 25 companies produce Chlorella in Europe with different growth technologies and applications. C. vulgaris has a long history of use as a food source and contains a unique and diverse composition of functional macro- and micro-nutrients including proteins. Chlorella vulgaris is a green unicellular microalgae with biological and pharmacological properties important for human health. C. vulgaris has a long history of use as a food source and contains a unique and diverse composition of functional macro- and micro-nutrients including proteins, omega-3 polyunsaturated fatty acids, polysaccharides, vitamins and minerals. Clinical trials have suggested that supplementation with C. vulgaris can ameliorate amelioration hyperlipidemia and hyperglycemia, and protect against oxidative stress, cancer and chronic obstructive pulmonary disease.
We are pleased to announce the confirmation of these speakers:
Programme available soon.
€ 300 regular
€ 235 for EABA members
50% increase for tickets booked within the last 10 days.
No VAT is charged. Payment per credit card or Ideal. Invoice provided.
When you need an invoice to make a bank transfer, fill out all details in the registration form and send a mail to firstname.lastname@example.org. The invoice can be prepared by the organisers. Please note: all payments have to be made before the start of the webinar.
Click on the button below to register. You’ll be redirected to the registration page https://www.aanmelder.nl/124296. This page will open in a new window.
Jörg Ullmann (Roquette Klotze)